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ABSTRACT: Data on predictors of gestational exposure to poly- and
perfluoroalkyl substances (PFASs) in the United States are limited. To fill in
this gap, in a multiethnic cohort of Ohio pregnant women recruited in 2003−
2006, we measured perfluorooctanesulfonate (PFOS), perfluorooctanoate
(PFOA), and six additional PFASs in maternal serum at ∼16 weeks gestation
(N = 182) and delivery (N = 78), and in umbilical cord serum (N = 202).
We used linear regression to examine associations between maternal serum
PFASs concentrations and demographic, perinatal, and lifestyle factors.
PFASs concentrations in maternal sera and in their infants’ cord sera were
highly correlated (Spearman rank correlation coefficients = 0.73−0.95). In
71 maternal-infant dyads, unadjusted geometric mean (GM) concentrations
(95% confidence interval) (in μg/L) in maternal serum at delivery of PFOS
[8.50 (7.01−9.58)] and PFOA [3.43 (3.01−3.90)] were significantly lower than at 16 weeks gestation [11.57 (9.90−13.53],
4.91 (4.32−5.59), respectively], but higher than in infants’ cord serum [3.32 (2.84−3.89), 2.85 (2.51−3.24), respectively]
(P < 0.001). Women who were parous, with a history of previous breastfeeding, black, or in the lowest income category had
significantly lower PFOS and PFOA GM concentrations than other women. These data suggest transplacental transfer of PFASs
during pregnancy and nursing for the first time in a U.S. birth cohort.
■ INTRODUCTION
Poly- and perfluoroalkyl substances (PFASs) are synthetic
fluorinated chemicals that have been used in a wide range of
consumer products and industrial applications over six decades.1
Because the remarkable strength of the fluorine−carbon covalent
bond confers thermal and chemical stability, some PFASs are
highly resistant to both chemical and biological degradation
under normal environmental conditions.1
The global occurrence of certain PFASs, persistence in the
environment and bioaccumulation in biota have raised concerns
about human exposures to PFASs,2 and human biomonitoring has
gained importance for exposure assessment of PFASs in the general
population of several countries.3−9 While human exposure to PFASs
is well recognized, pregnant women, infants, and young children are
often poorly represented in general population biomonitoring
surveys. Biomonitoring studies among subpopulations susceptible
to the effects of potentially harmful environmental chemicals,
such as PFASs, are of interest because exposures during these
critical windows of susceptibility may impact health later in life.
Pregnant women worldwide are exposed to PFASs10−24
even though data on pregnant women in the United States are
limited14,15,25and several studies have identified previous
pregnancies, breastfeeding duration, and diet as important
determinants of exposure to PFASs among pregnant
women.12,14,15,23,26 Of interest, PFASs can be transported
across the placenta; several PFASs have been detected in
cord serum.13,17,18,20,21,24,27−43 Furthermore, the transfer of
PFASs across the placenta may differ depending on the
compound. For example, available scientific evidence sug-
gest that PFOA may pass through the placenta more easily
than PFOS.17,20,21,24,28,30,32,34,35,39,41 Data on paired maternal
and cord blood PFASs concentrations also exist for
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populations around the world, but not in the United
States.13,17,18,20,21,24,28,30,32,34,35,37,39,41,43
To improve our understanding of in utero exposure to
PFASs among U.S. women, we quantified the concentrations of
PFASs in maternal serum during pregnancy and at delivery, and
in cord sera, and evaluated the trends of PFASs concentrations
and their correlations during gestation in a cohort of Ohio
women. We also determined the correlations of select PFASs
for paired maternal−cord sera, and examined associations
between maternal serum PFASs concentrations and demo-
graphic and lifestyle factors.
■ EXPERIMENTAL SECTION
Study Population. Data were collected from mothers
and their children participating in the Health Outcomes and
Measures of the Environment (HOME) Study, an ongoing
prospective birth cohort in the Cincinnati, Ohio (U.S.A.)
metropolitan area, designed to examine low-level exposure to
environmental toxicants and the efficacy of injury and lead
hazard controls in the home. Between March 2003 and January
2006, pregnant women were recruited from seven prenatal
clinics associated with three hospitals. Eligibility criteria for the
study included ≤19 weeks of gestation, age ≥18 years, living in
a house built before 1978, negative HIV status, and not taking
medications for seizure or thyroid disorders. HOME Study staff
mailed letters to 5184 women who were ≥18 years of age and
living in a house built before 1978. Of the 1263 eligible women,
468 provided informed consent and enrolled in the study. The
Institutional review boards of all involved research institutions,
hospitals, and laboratories approved the study protocol.
Women provided three serum samples collected at
approximately 16 and 26 weeks of gestation and within 24 h
of parturition. For this project, we used the concentrations of
PFASs in the 16 week samples, collected at the women’s prenatal
care appointment visit, to estimate the woman’s gestational
exposure to PFASs. Umbilical cord blood was collected at
the time of infant delivery. We analyzed a total of 182 (16-week),
78 (delivery), and 202 (cord) serum samples, including
71 maternal-infant dyads with mothers’ PFASs concentrations
available at both 16 week of gestation and delivery.
Quantification of PFASs Concentrations in Serum. By
using a modification of our analytical method,44 we measured
eight PFASs in maternal and umbilical cord sera: 2-(N-methyl-
perfluorooctane sulfonamido) acetate (Me-PFOSA-AcOH),
2-(N-ethyl-perfluorooctane sulfonamido) acetate (Et-PFOSA-
AcOH), perfluorohexanesulfonate (PFHxS), perfluorooctanesul-
fonate (PFOS), perfluorooctanoate (PFOA), perfluorononanoate
(PFNA), perfluorodecanoate (PFDeA), and perfluorooctane
sulfonamide (PFOSA). We used the following isotope-labeled






18O2-PFOSA. To account for potential
matrix effects, we spiked the calibration standards into calf serum
(Gibco, Grand Island, NY). Briefly, we added 325 μL of 0.1 M
formic acid and 25 μL of internal standard solution to 50 μL
of serum in a 1.5 mL polypropylene autosampler vial, and the
spiked serum was vortex-mixed. The sera vials were placed on
a Symbiosis online SPE system (Spark Holland, Plainsboro, NJ)
for the preconcentration of the analytes on a Polaris C18
cartridge (7 μm, 10 × 1 mm; Spark Holland). The analytes were
transferred onto a Betasil C8 HPLC column (3 × 50 mm, 5 μm;
ThermoHypersil Keystone, Bellefonte, PA), separated by HPLC
(mobile phase A: 20 mM ammonium acetate in water, pH = 4;
mobile phase B: acetonitrile), and detected by negative-ion
TurboIonspray-tandem mass spectrometry on an API 4000 mass
spectrometer (Applied Biosystems, Foster City, CA). The limits
of detection (LODs) were 0.087 μg/L for Me-PFOSA-AcOH,
0.082 μg/L for PFNA, 0.1 μg/L for PFHxS, PFOA, PFDeA,
PFOSA, and Et-PFOSA-AcOH, and 0.2 μg/L for PFOS. The
reported concentrations are for the sum of linear and branched
isomers of PFOS and PFOA. Low-concentration quality control
materials (QCs) and high-concentration QCs, prepared from a
calf serum pool, were analyzed with the study samples and with
reagent and serum blanks to ensure the accuracy and reliability of
the data.44 The coefficients of variation of repeated measurements
of the QCs within a period of almost one year are around 6%
(http://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/PFAS_
F_Polyfluorinated_Compounds_met.pdf).
Predictors of PFASs Concentrations. We examined the
association between maternal serum PFASs concentrations and
demographic, perinatal, and environmental variables collected
from questionnaires and biological samples. These variables
have been used as covariates in PFASs-related epidemiological
studies. Demographic factors included maternal age, education,
race, and household income. Perinatal and maternal factors
included gestational age, parity, history of breastfeeding,
prepregnancy body mass index (BMI), and serum cotinine.
Serum cotinine concentrations were measured in maternal
samples collected at 16 weeks of gestation and within 24 h of
birth, as well as in cord serum at delivery.
Statistical Analysis. All analyses were conducted using SAS
version 9.1 (SAS Institute, Cary, NC). For statistical analysis,
PFAS concentrations were log10 transformed. For concentrations
below the LOD, we used LOD divided by the square root of 2.45
We calculated the median concentration for maternal and cord
sera, and for the 71 maternal-infant dyads, we used the non-
parametric Wilcoxon signed rank test to compare each woman’s
medians at different time points over the course of pregnancy
and in their infant’s cord sera. Moreover, for the 71 pairs with
available maternal serum concentrations at 16 weeks and birth,
and cord serum concentrations at delivery, we calculated the
unadjusted geometric mean (GM) PFASs concentrations, and
used a paired t test to compare the unadjusted GM for each
pair of time points. We also determined the Spearman rank
correlations among the log10 transformed concentrations of
PFASs in maternal and cord sera at birth, and in maternal sera at
birth and at 16 weeks gestation. Statistical significance was set at
P < 0.05 for all analyses.
We used linear regression to model separately the log10
transformed PFAS concentrations of cord serum or mothers’
serum at 16 weeks gestation for each predictor variable
(covariate). We included the following covariates one at a time:
gestational age (term [ ≥ 37 weeks], preterm [<37 weeks]),
maternal age, parity, prepregnancy BMI (obese [≥30 kg/m2],
overweight [25−29.9 kg/m2], normal weight [18.5−24.9 kg/m2],
underweight [<18.5 kg/m2]), history of previous breast feeding
(yes/no), household income (<$20K, $20K−$40K, $40K−<$80K,
>$80K), maternal education, race (non-Hispanic white, non-
Hispanic black, other), and serum cotinine [active (>3 μg/L),
secondhand (0.015−3 μg/L), or no (<0.015 μg/L) environ-
mental tobacco smoke exposure]. Cotinine in serum was
measured using HPLC-tandem mass spectrometry (LOD =
0.015 μg/L) as described before.46 We calculated the GM
concentrations and their 95% confidence intervals (CI) by
categories of each predictor. Beta coefficients were exponentiated
from the regression models to produce the ratio of PFAS GM
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concentrations between categories of predictor variables. Thus,
numeric estimates indicate that the GM concentrations were
higher (>1) or lower (<1) for the predictor in that category
compared with the reference category.
■ RESULTS
The frequency of detection and concentrations of 8 PFASs in
maternal sera during pregnancy and delivery and in cord sera
are shown in Table 1 for the 71 paired maternal/infant samples
and in the Supporting Information, SI (Tables S1 and S2). The
geometric means of concentration ratios for the 71 dyads are
also shown in the SI (Table S3). We detected PFOS, PFOA,
PFNA, and PFHxS in more than 90% of the paired samples,
and Me-PFOSA-AcOH in about 90%. For the other analytes,
we did not perform additional analyses because the frequency
of detection was <30% at all of the time points examined (i.e.,
Et-PFOSA-AcOH, PFOSA) or the median was close to the
LOD (i.e., PFDeA). The median concentrations in cord serum
were lower than the corresponding paired maternal concen-
trations (Table 1).
We determined the Spearman rank correlations between the
log10 transformed maternal concentrations of Me-PFOSA-
AcOH, PFHxS, PFOS, PFOA, and PFNA at 16 weeks and at
delivery and their infants’ cord serum concentrations (Table 2).
Correlations between the concentrations in maternal and infants’
samples collected at delivery (Spearman rank correlation
coefficient (r) = 0.79−0.92) and between the maternal samples
at 16 weeks gestation and the infants’ cord serum (r = 0.73−
0.95) were high. The PFAS concentrations in maternal sera at
16 weeks gestation and at delivery were also highly correlated
(r = 0.84−0.94).
We observed a statistically significant decrease in the
unadjusted GM maternal serum concentrations of most PFASs
from 16 weeks gestation to delivery (all paired t test P values
<0.001) (Figure 1). Still, maternal concentrations of PFOS,
PFOA, PFNA, and PFHxS at birth were significantly higher
than cord concentrations (all paired t test P values <0.001),
but were lower for Me-PFOSA-AcOH (P = 0.01). Specifically,
the maternal geometric mean concentrations of PFOS, PFOA,
PFNA, and PFHxS decreased 25−43%, depending on the com-
pound, between 16 weeks gestation and delivery (SI Table S4).
The percent change of geometric mean concentrations between
maternal and cord sera during gestation and delivery for these
five PFASs are shown in the SI (Table S4).
The Wilcoxon signed rank test showed the same pattern
for the medians: maternal serum median concentrations of
PFOS, PFOA, PFNA, and Me-PFOSA-AcOH decreased signifi-
cantly from 16 weeks gestation to birth (all P values <0.001).
Table 1. Median Concentrations (in μg/L) of PFASs and
Frequency of Detection for 71 Paired Maternal−Infant












<LOD [23.9] <LOD [9.9] <LOD [11.3]
Me-PFOSA-
AcOH
0.50 [100] 0.20 [88.7] 0.30 [93.0]
PFOSA <LOD [1.4] <LOD [0] <LOD [0]
PFHxS 1.20 [98.6] 1.20 [93.0] 0.60 [97.2]
PFOS 12.70 [100] 8.50 [100] 3.50 [98.6]
PFOA 4.80 [100] 3.30 [100] 3.10 [100]
PFNA 0.82 [100] 0.66 [100] 0.41 [98.6]
PFDeA 0.20 [97.2] 0.20 [90.1] <LOD [16.9]
aThe limits of detection (LODs) were 0.087 μg/L (Me-PFOSA-
AcOH), 0.082 μg/L (PFNA), 0.1 μg/L (PFHxS, PFOA, PFDeA,
PFOSA, Et-PFOSA-AcOH), and 0.2 μg/L (PFOS).
Table 2. Spearman Rank Correlation Coefficients between
Log10 Concentrations of Select PFASs in Maternal Serum
at 16 Weeks Gestation, At Birth, And in Infant Cord Serum
(n = 71 Mother−Infant Pairs)a,b
analyte
maternal serum at
16 weeks and at
birth (N = 71)
maternal serum at 16
weeks and infant cord








PFHxS 0.92 0.95 0.89
PFOS 0.87 0.83 0.82
PFOA 0.94 0.92 0.88
PFNA 0.88 0.77 0.79
aSelected PFASs were those detected in >60% of samples at all time
points. bP values for all the comparisons were <0.05.
Figure 1. Concentrations (in μg/L) for select PFASs in maternal
serum at 16 weeks gestation and delivery, and in cord serum (n = 71
paired samples). Whiskers represent the 5th and 95th percentiles. The
top and bottom edges of each box represent the 75th and 25th
percentiles, respectively. The horizontal line in each box represents
the median. Circles represent observations outside the 10th and 90th
percentiles.
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Also, maternal median concentrations of PFOS, PFOA, PFNA,
and PFHxS at delivery were significantly higher than the
infants’ cord serum concentrations (P values <0.001). The
maternal median concentrations of Me-PFOSA-AcOH were
lower than in cord serum, but they did not reach statistical
significance (P = 0.46). Because concentrations of Me-PFOSA-
AcOH in the mothers’ serum at birth and their infants’ cord
serum were close to the LOD, these data should be interpreted
cautiously.
Maternal serum concentrations of PFOS, PFOA, PFNA, and
PFHxS at 16 weeks gestation were lower in women younger
than 25 years of age compared with older women, but only
reached statistical significance for PFOS and PFHxS (Table 3).
Non-Hispanic black women and women with the lowest house-
hold income had significantly lower concentrations of PFOS,
PFOA, PFNA, and PFHxS than non-Hispanic white women and
women in the most affluent households, respectively. Obese
women had significantly lower PFOS and PFNA concentrations
than other women; active smokers had significantly lower PFOS
concentrations than nonsmokers or second-hand smokers;
women with a high school education or below had significantly
lower PFHxS concentrations than women having more than a
high school education. Also, a history of previous breastfeeding
was inversely and significantly associated with PFOS and PFOA
serum concentrations, and nulliparous women had signifi-
cantly higher concentrations of PFOS and PFOA than parous
women (Table 3). Breastfeeding and parity were significantly
associated with each other (χ2 test P-value = <0.001), but parous
women’s GM concentrations were essentially the same when
we included parity and breastfeeding history together (data not
shown) or separately (Table 3) in the model. For example,
GM concentrations of PFOS were 13.19 μg/L (parity = 1) and
11.3 μg/L (parity >1) compared to 13.06 μg/L and 11.37 μg/L,
respectively. Gestational age (preterm vs term) was not
significantly associated with the concentrations of any of the
PFASs examined. Cord serum concentrations varied similarly
by demographic, perinatal, and lifestyle factors (SI Table S5)
and will not be discussed further.
■ DISCUSSION
We found that serum concentrations of PFOS, PFOA, PFNA,
and PFHxS among a group of U.S. pregnant women in 2003−
2006 were within the concentration ranges of these compounds
in the U.S. general population.5 These results suggest that
PFAS exposure is ubiquitous in U.S. pregnant women. This
information is important because, to date, published data on
background exposure to PFASs among pregnant women in the
United States are limited to 180 pregnant participants of the
2003−2008 National Health and Nutrition Examination Survey
(NHANES).14,25
Of interest, the PFOS median concentrations in these
Cincinnati women recruited during early gestation in 2003−
2006 (12.7 μg/L) are quite close to those reported for
NHANES 2003−2004 pregnant participants (12.0 μg/L), while
the PFOA median concentrations (4.8 μg/L) are about two
times higher (2.6 μg/L).14,25 These findings suggest similar
exposure to PFOS but higher exposure to PFOA for this cohort
of Cincinnati pregnant women compared to the U.S. general
population. Consistent with our findings, previous investigations
reported higher serum concentrations of PFOA, but not of other
PFASs, in a group of 6−8 year-old Cincinnati girls recruited
starting in the spring of 2004 from a school district in northern
Kentucky47,48 and in more than 65 000 residents of six water
districts in two states near Parkersburg, West Virginia enrolled
in 2005−2006.49 The source of the exposure to PFOA in these
populations was identified to be drinking water from the Ohio
River that had been contaminated with PFOA.50 Therefore,
we speculate that the higher than background concentrations
of PFOA in our study population may also be related to the
consumption of PFOA contaminated drinking water as reported
recently for Cincinnati girls recruited around the same time48 as
the HOME Study participants.
The observed PFAS concentration sequence PFOS≫ PFOA
> PFNA ∼ PFHxS in maternal and cord sera and the strong
correlations between the PFAS serum concentrations between
all of the maternal and infant samples are consistent with
previous reports.13,17,18,20,21,24,28,30,32,34,35,37,39,41,43 The signifi-
cantly higher maternal serum concentrations of these PFASs
at 16 weeks than both the maternal and infant’s concentrations
at birth suggest transplacental transfer of PFASs. Of interest,
the ratio of concentrations between maternal and infant’s
samples varied depending on the compound. For example,
at delivery, the ratio between the median maternal and cord
serum concentration was about 1 for PFOA but ∼2 for PFOS.
These ratios, which are similar to those previously reported,
indicate that there are differences in the transplacental transfer
of these compounds.17,20,21,24,28,30,32,34,35,39,41
Our results are consistent with other studies that examined
PFAS concentrations in serial maternal blood samples collected
during pregnancy, and compared maternal and infant’s concentra-
tions at birth.18,21 Glynn et al. reported a significant decline
in mean serum concentrations between the first and third
trimester of pregnancy for PFOS, PFOA, and PFNA among 19
primiparous Swedish women.18 Fromme et al. did not observe
significant concentration differences of PFOS, PFOA, PFHxS,
and PFNA between maternal samples collected at 34−37 weeks
of pregnancy and at delivery from 27 German women,21 but the
time interval between the two maternal samples was much
shorter than the interval Glynn et al. examined. Consistent with
our findings, both research groups reported lower concentrations
of PFASs in the cord serum compared with maternal samples.
Thus, our results, which show strong correlations between the
concentrations of all five PFASs in the maternal sera early during
pregnancy and at birth, are consistent with these two previous
studies,18,21 while also providing information for PFHxS and
Me-PFOSA-AcOH, and with a larger sample size.
We found that maternal age was positively associated with
PFAS concentrations during pregnancy. PFOS, PFOA, PFNA,
and PFHxS concentrations were lower in women younger than
25 years of age compared with older women. In the early 2000s,
3M, the main manufacturer of PFOS worldwide, discontinued
the production of PFOS precursors and related compounds
(including PFHxS and PFOA) in the United States. This fact
may explain why younger women had lower concentrations
of these compounds than older women, who may have had
experienced increased exposures when production of these
PFASs peaked during the 1980s−1990s time period.51 NHANES
data during 1999−2008 also suggest that PFOS, PFOA, PFHxS,
and PFNA concentrations in females increased with age.52
Non-Hispanic black women and women who reported the
lowest household income had lower concentrations of PFOS,
PFOA, PFNA, and PFHxS than non-Hispanic white women and
women in the more affluent households, respectively. These
results are in agreement with findings from the U.S. general
population. Specifically, 1999−2008 NHANES data also suggest
that non-Hispanic black females had lower concentrations of
Environmental Science & Technology Article
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PFOA and PFHxS than non-Hispanic white females.52 Similarly,
in an analysis of 2003−2008 NHANES data, PFOA and PFOS
concentrations were higher in more affluent populations.53
The reason for these differences is unknown, but may reflect
differences related to lifestyle (e.g., use of PFASs-containing
products), diet, physiology (e.g., elimination), or a combination
of the above.52
Active smokers had significantly lower PFOS concentrations
than nonsmokers or second-hand smokers. Of interest, the
associations between smoking and PFASs exposure are
inconsistent among studies. In agreement with our findings,
current Danish male smokers had lower PFOA and PFOS
plasma concentrations than never smokers.54 By contrast,
smoking was positively associated with serum concentrations
of PFNA and PFOA in 17−39 year old 2003−2008 NHANES
female participants.14 In another study, smoking was not
associated with concentrations of PFASs in French women’s
breast milk.55
Obese women had significantly lower PFOS and PFNA
concentrations than other women. Like for smoking, there is no
consistency in the literature about the potential associations
between exposure to PFASs and BMI. Similar to our findings,
plasma concentrations of PFOS and PFOA were inversely
associated with BMI in Danish men.54 However, in Korean
adolescents and adults,7,56 serum concentrations of several
PFASs, including PFHxS, PFOS, PFOA, and PFNA, showed
a positive association with BMI. Finally, others have reported
no associations between plasma concentrations of PFASs (e.g.,
PFOS, PFOA, PFHxS, and PFNA) in a group of Vietnamese
pregnant women57 or middle-aged Norwegian women.58
Interpreting these results is difficult because of the differences
in study populations and inconsistent findings among studies.
Nulliparous women had significantly higher concentrations
of PFOS and PFOA than parous women, in agreement with
previous studies.12,26,28,40,59,60 We also observed a significant
decrease in maternal concentrations of these compounds from
16 weeks gestation to delivery. Together, these findings suggest
gestational transfer of PFASs to the fetus.17,20,28,30,32,34,40
However, we cannot rule out that physiologic changes
occurring during pregnancy (e.g., increased maternal blood
volume, fat and total body water; decreased plasma protein
concentrations, especially albumin) may also be related to the
observed decrease in maternal PFAS concentrations.61,62
Finally, we observed that a history of previous breastfeeding
was inversely associated with PFOS and PFOA serum con-
centrations, suggesting that breastfeeding may further decrease
the mother’s body burden of these compounds and contribute
to infants’ exposure to PFASs.14,21,35,37,43,55,63−72 Consistent
with our findings, the duration of being breast-fed was also
positively associated with serum PFOA concentrations among
6−8 year-old girls in Greater Cincinnati (N = 353) and the San
Francisco Bay Area (N = 351).48
Our study has several limitations. We lacked detailed
information on some potentially important sources of PFAS
exposure including paper/cardboard use, packaged food
consumption, or use of fabric or carpet treatment products
during pregnancy. Furthermore, we did not examine sources of
dietary exposure as dietary variables collected in the larger
HOME Study were designed to assess exposures to heavy
metals, pesticides and other persistent pollutants rather than
PFASs. Lastly, results from this study population may not be
generalizable to the general population of U.S. pregnant women
because our participants resided in an area in the United States
where the nature of the exposure to at least some of the PFASs
(i.e., PFOA) may have differed from the rest of the country.
Nonetheless, our data support the hypothesis that PFASs
transfer from the mother to her child, and suggests that nursing
may decrease a woman’s body burden of PFASs. Our findings
also show for the first time in a U.S. longitudinal birth cohort
that exposure to PFASs among a population of pregnant women
is a function of age, race, household income, parity, and previous
history of breastfeeding. Future research should build on these
results to examine the impact of prenatal and postnatal exposure
to these persistent organic pollutants among the children in the
HOME Study and other birth cohorts.
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